NCT00000989View on ClinicalTrials.gov

The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

Not specified

Study Completion Date

July 31, 1992

Conditions
Cytomegalovirus RetinitisHIV Infections
Interventions
DRUG

Zidovudine

DRUG

Sargramostim

DRUG

Ganciclovir

Trial Locations (4)

10021

Memorial Sloan-Kettering Cancer Ctr., New York

90095

UCLA CARE Center CRS, Los Angeles

275997215

Unc Aids Crs, Chapel Hill

02215

Beth Israel Deaconess - East Campus A0102 CRS, Boston

Sponsors

Collaborators (1)

Schering-Plough
All Listed Sponsors
collaborator

Schering-Plough

INDUSTRY

collaborator

Hoffmann-La Roche

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH